Scholars Central

Research articlePublished 2015

Conversion Rate to Resectability in Colorectal Cancer Liver Metastases: Need for Criteria Adapted to Current Therapy.

Authors: Timofeiov S, Marinca M, Camelia Bar, Mihaela Elena Breaban, Drug V, Scripcariu V

Journal of Surgery

Volume 11 · Issue 1 · Pages 1–14

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Therapeutic strategy for patients with colorectal cancer liver metastases (CRLM) is based on good monitoring and correct assignment to classes of liver resectability based on imaging criteria, taking into account the surgical risk. Objective: To identify the post-treatment time frame for confirming resectability (conversion to resecability) or permanent unresectability. Methods: The study is a prospective analysis based on a Scientific Protocol (Surveillance of patients with colorectal cancer liver metastases) used in the Ist Surgical Oncology Unit, Regional Institute of Oncology Ia?i, Romania. Surgical treatment, oncologic treatment, response to therapy , postoperative surgical complications, were assessed at 3, 6 and 9 months after start of the study. Results: In the interval July 2012 - January 2014, 106 patients were diagnosed with CRLM. According to the classes of liver resectability the patients were divided into four groups: group I (clear resectability), group II (possibly resectability), group III (susceptible resectability), group IV (unresectable metastases). Relevant for the study were only groups II and III. Thus, in group II patients the rate of conversion to resectability was 23.07% and in group III patients 26.66%. These results were obtained after 3, 6 and 9 months of therapy, respectively. Conclusions: Rigorous surveillance of patients with CRLM according to a well-established scientific protocol, and their assignment to liver resectability classes represent the first step ofthe oncosurgical therapeutic strategy. An improvement in the rate of conversion to resectability could be achieved through regular assessment of treatment response based on international criteria that should include besides the number and size of target lesions the posttherapy morphological tumor changes.

Subjects

Surgery

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Surgery.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Surgery
  • SubjectSurgery
  • BylineArticles whose byline prints “Timofeiov S”
  • BylineArticles whose byline prints “Marinca M”
  • BylineArticles whose byline prints “Camelia Bar”
  • BylineArticles whose byline prints “Mihaela Elena Breaban”
  • BylineArticles whose byline prints “Drug V”
  • BylineArticles whose byline prints “Scripcariu V”